{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:53:30Z","timestamp":1772848410661,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1138798"],"award-info":[{"award-number":["OPP1138798"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.vaccine.2025.126712","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T07:37:16Z","timestamp":1736494636000},"page":"126712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Immunogenicity of yellow fever vaccine co-administered with 13-valent pneumococcal conjugate vaccine in rural Gambia: A cluster-randomised trial"],"prefix":"10.1016","volume":"47","author":[{"given":"Isaac","family":"Osei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Schmidt-Chanasit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul V.","family":"Licciardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ousman","family":"Secka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"D'Alessandro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasheed","family":"Salaudeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Golam","family":"Sarwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ed","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuredin I.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cattram","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant A.","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.126712_bb0005","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64670","article-title":"The global burden of yellow fever","volume":"10","author":"Gaythorpe","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.vaccine.2025.126712_bb0010","series-title":"Disease Outbreak News; Yellow fever in African Region (AFRO)","year":"2024"},{"issue":"32","key":"10.1016\/j.vaccine.2025.126712_bb0015","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1016\/j.vaccine.2019.06.063","article-title":"Differences between coverage of yellow fever vaccine and the first dose of measles-containing vaccine: a desk review of global data sources","volume":"37","author":"Adrien","year":"2019","journal-title":"Vaccine"},{"issue":"05","key":"10.1016\/j.vaccine.2025.126712_bb0020","first-page":"33","article-title":"Yellow fever fact sheet:(revised in December 2009)","volume":"85","author":"Organization WH","year":"2010","journal-title":"Weekly Epidemiological Record= Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire"},{"key":"10.1016\/j.vaccine.2025.126712_bb0025","series-title":"Principles and practice of pediatric infectious diseases","first-page":"76","article-title":"Understanding, controlling, and preventing infectious diseases","author":"Maryanne","year":"2012"},{"issue":"23","key":"10.1016\/j.vaccine.2025.126712_bb0030","first-page":"647","article-title":"Yellow fever vaccine booster doses: recommendations of the advisory committee on immunization Practices, 2015","volume":"64","author":"Staples","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1722","key":"10.1016\/j.vaccine.2025.126712_bb0035","first-page":"2023","article-title":"New Vaccine introductions in WHO African region between 2000 and 2022","volume":"11","author":"Iwu-Jaja","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.126712_bb0040","series-title":"Background paper on immunologic response to measles-containing vaccines (MCVs) and yellow fever (YF) vaccines when co-administered","article-title":"Yellow Fever Working Group","author":"SAGE","year":"2018"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126712_bb0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12879-023-08114-1","article-title":"Immune response to co-administration of measles, mumps, and rubella (MMR), and yellow fever vaccines: a randomized non-inferiority trial among one-year-old children in Argentina","volume":"23","author":"Vizzotti","year":"2023","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126712_bb0050","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S2214-109X(16)30075-4","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine when given with measles\u2013rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in the Gambia","volume":"4","author":"Clarke","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"37","key":"10.1016\/j.vaccine.2025.126712_bb0055","doi-asserted-by":"crossref","first-page":"6327","DOI":"10.1016\/j.vaccine.2011.05.019","article-title":"Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella","volume":"29","author":"Silva","year":"2011","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.vaccine.2025.126712_bb0060","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1016\/j.vaccine.2017.09.047","article-title":"CHRONOVAC VOYAGEUR: a study of the immune response to yellow fever vaccine among infants previously immunized against measles","volume":"35","author":"Goujon","year":"2017","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2025.126712_bb0065","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1016\/j.vaccine.2007.01.053","article-title":"Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213\/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program","volume":"25","author":"Vaccine CGfSwYF","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126712_bb0070","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1016\/S2214-109X(17)30043-8","article-title":"Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in south African children: a case-control study","volume":"5","author":"Cohen","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126712_bb0075","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126712_bb0080","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126712_bb0085","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(20)30880-X","article-title":"Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in the Gambia: 10 years of population-based surveillance","volume":"21","author":"Mackenzie","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126712_bb0090","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S2214-109X(18)30422-4","article-title":"Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis","volume":"7","author":"Chen","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126712_bb0095","first-page":"93","article-title":"Pneumococcal conjugate vaccine for childhood immunization\u2014WHO position paper","volume":"82","author":"Organization WH","year":"2007","journal-title":"Weekly Epidemiological Record= Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126712_bb0100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1473-3099(17)30654-0","article-title":"Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1+ 1) compared with two primary doses and a booster (2+ 1) in UK infants: a multicentre, parallel group randomised controlled trial","volume":"18","author":"Goldblatt","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126712_bb0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijid.2017.04.015","article-title":"A new paradigm in pneumococcal conjugate vaccination: moving from individual to herd protection","volume":"60","author":"Rodgers","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126712_bb0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13063-021-05949-4","article-title":"Pneumococcal conjugate vaccination schedules in infants\u2014acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study","volume":"23","author":"Mackenzie","year":"2022","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126712_bb0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13063-021-05964-5","article-title":"A cluster-randomised, non-inferiority trial of the impact of a two-dose compared to three-dose schedule of pneumococcal conjugate vaccination in rural Gambia: the PVS trial","volume":"23","author":"Mackenzie","year":"2022","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126712_bb0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1286-4579(00)00288-4","article-title":"Stability-related studies on 17D yellow fever vaccine","volume":"2","author":"Perraut","year":"2000","journal-title":"Microbes Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126712_bb0125","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13063-024-08036-6","article-title":"Pneumococcal conjugate vaccination schedules in infants\u2014acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study: statistical analysis plan","volume":"25","author":"Mackenzie","year":"2024","journal-title":"Trials"},{"issue":"44","key":"10.1016\/j.vaccine.2025.126712_bb0130","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1016\/j.vaccine.2022.09.031","article-title":"Attendance and vaccination at immunization clinics in rural Gambia before and during the COVID-19 pandemic","volume":"40","author":"Osei","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126712_bb0135","series-title":"Assessment and application of a cell line from pig kidney for plaque assay and neutralization tests with twelve group B Arbo-viruses","author":"Westaway","year":"1966"},{"issue":"suppl_5","key":"10.1016\/j.vaccine.2025.126712_bb0140","doi-asserted-by":"crossref","first-page":"S586","DOI":"10.1093\/cid\/civ603","article-title":"Immunogenicity of yellow fever vaccine coadministered with MenAfriVac in healthy infants in Ghana and Mali","volume":"61","author":"Roy Chowdhury","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126712_bb0145","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S1473-3099(19)30323-8","article-title":"Long-term immunity against yellow fever in children vaccinated during infancy: a longitudinal cohort study","volume":"19","author":"Domingo","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2025.126712_bb0150","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0264-410X(98)00320-X","article-title":"Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine","volume":"17","author":"Stefano","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126712_bb0155","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1590\/S0034-89102004000500009","article-title":"Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial","volume":"38","author":"Camacho","year":"2004","journal-title":"Rev Saude Publica"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126712_bb0160","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41541-022-00595-6","article-title":"A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine","volume":"7","author":"Desai","year":"2022","journal-title":"npj Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126712_bb0165","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJMoa1710430","article-title":"Immunogenicity of fractional-dose vaccine during a yellow fever outbreak","volume":"381","author":"Casey","year":"2019","journal-title":"New England J Med"},{"issue":"44","key":"10.1016\/j.vaccine.2025.126712_bb0170","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1016\/j.vaccine.2020.08.042","article-title":"Yellow fever in children and adolescents previously immunized in Minas Gerais state","volume":"38","author":"Diniz","year":"2020","journal-title":"Brazil Vaccine"},{"key":"10.1016\/j.vaccine.2025.126712_bb0175","article-title":"Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection","volume":"5(1):54","author":"Staples","year":"2020","journal-title":"npj Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126712_bb0180","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1473-3099(20)30735-0","article-title":"Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in the Gambia: a phase 3, randomised, double-blind, non-inferiority trial","volume":"21","author":"Clarke","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"19","key":"10.1016\/j.vaccine.2025.126712_bb0185","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1016\/j.vaccine.2019.03.033","article-title":"Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines\u2013a phase II, randomised, observer-blind study in Gambian infants","volume":"37","author":"Odutola","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126712_bb0190","first-page":"1","article-title":"Grading of recommendations, assessment, development, and evaluation (GRADE) for use of yellow fever Vaccine booster doses","author":"Practices ACoI.","year":"2015","journal-title":"MMWR Recomm Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2500009X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2500009X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T03:15:55Z","timestamp":1739416555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2500009X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":38,"alternative-id":["S0264410X2500009X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126712","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity of yellow fever vaccine co-administered with 13-valent pneumococcal conjugate vaccine in rural Gambia: A cluster-randomised trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126712","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126712"}}